{"slideshow_credits": null, "snippet": "Bayer\u2019s $14.2 billion acquisition of Merck\u2019s consumer care business makes strategic sense and sizable tax breaks will help, writes Olaf Storbeck of Reuters Breakingviews.", "abstract": "Bayer\u2019s $14.2 billion acquisition of Merck\u2019s consumer care business makes strategic sense and sizable tax breaks will help, writes Olaf Storbeck of Reuters Breakingviews.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Olaf", "role": "reported", "lastname": "STORBECK", "rank": 1, "organization": ""}], "original": "By OLAF STORBECK"}, "web_url": "http://dealbook.nytimes.com/2014/05/06/how-bayers-buy-makes-sense/", "lead_paragraph": null, "headline": {"main": "How Bayer's Buy Makes Sense", "kicker": "DealBook"}, "_id": "5369420a38f0d86f20fb8bd0", "word_count": "369", "multimedia": [{"height": 126, "url": "images/2014/05/07/business/dbpix-bayer2/dbpix-bayer2-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/05/07/business/dbpix-bayer2/dbpix-bayer2-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 365, "url": "images/2014/05/07/business/dbpix-bayer2/dbpix-bayer2-articleLarge.jpg", "legacy": {"xlarge": "images/2014/05/07/business/dbpix-bayer2/dbpix-bayer2-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "365"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/05/07/business/dbpix-bayer2/dbpix-bayer2-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/05/07/business/dbpix-bayer2/dbpix-bayer2-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-05-06T16:10:24Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Merck & Company Inc", "rank": "2"}, {"name": "organizations", "value": "Bayer AG", "rank": "1"}, {"name": "subject", "value": "Tax Credits, Deductions and Exemptions", "rank": "3"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}